Keyphrases
2-pyridone
47%
26S Proteasome
6%
3D Neurospheres
35%
5-dicarbonitriles
47%
AKT Pathway
11%
AKT2
47%
Amino
47%
Anti-glioma
47%
Anticancer Activity
43%
Anticancer Bioactivity
47%
Anticancer Properties
15%
Apoptosis
6%
Betaine
15%
Bioactive
15%
Blood-brain Barrier
6%
Brain Endothelial
6%
Breast
15%
Breast Cancer Burden
6%
Cancer Cells
23%
Cancer Progression
47%
Catalytic Synthesis
47%
Chlorophenyl
47%
Clinically Significant
31%
Co-target
6%
COVID-19
20%
COVID-19 Patients
47%
COVID-19 Progression
6%
Cytotoxicity
11%
Druggable Targets
6%
Dual Inhibition
47%
DYRK2
47%
EC50
11%
Endothelial Cells
6%
Endothelial Dysfunction
47%
Enhanced Cytotoxicity
15%
Enhanced Permeability
6%
Excessive Inflammatory Response
6%
Expression Profile
6%
Gene Expression Omnibus
6%
Glioblastoma
18%
Glioblastoma Cell Lines
27%
Glioblastoma Cells
31%
Glioblastoma Progression
47%
Glioma
11%
Glioma Cell Lines
11%
Glioma Cells
11%
Glioma Growth
11%
Glioma Malignancy
11%
Glioma Stem Cells
23%
Growth Inhibition
11%
Guanidine Carbonate
15%
Heart Attack
6%
Heat Shock Factor 1 (HSF1)
47%
HSF1 Inhibitors
13%
Immune Inflammation
6%
Immune Response
6%
Inflammation
6%
Inflammatory Diseases
6%
Inhibitor Resistant
6%
Inhibitory Activity
23%
Inhibitory Properties
11%
Innate Immunity
6%
Innate Inflammation
6%
Ischemic Stroke
6%
KRIBB11
6%
Liver
15%
Lung Cancer
15%
Lung Primary
15%
Malignancy
6%
Natural Products
15%
Neurological Injury
6%
Neurosphere Formation
23%
Non-cancer
23%
Novel Therapeutics
11%
Oncogenic Kinases
6%
Oncogenic Pathways
11%
One-pot Two-step Reaction
47%
Organ Failure
6%
Orthotopic Xenograft Model
6%
Patient Survival
11%
Patient-derived
35%
Protease Inhibitors
22%
Proteostasis
6%
Proteotoxic Stress
6%
Pyrano
47%
Pyrazole
47%
Resistant Cells
6%
SARS-CoV-2 Infection
13%
Single-cell Transcriptome Analysis
6%
Single-cell Transcriptomics
47%
Small Molecule Inhibitors
15%
Small Molecule Kinase Inhibitors
15%
Stimulator of Interferon Genes (STING)
6%
Survival Mechanism
6%
Transcription Factor
20%
Transcriptomic Changes
6%
Transcriptomic Data
6%
Transcriptomic Landscape
6%
Triple-negative Breast Cancer
6%
Pharmacology, Toxicology and Pharmaceutical Science
Blood-Brain Barrier
6%
Brain Ischemia
6%
Carcinogenesis
11%
Cytotoxicity
21%
EC50
11%
Endothelial Dysfunction
47%
Glioblastoma
100%
Guanidine
9%
Heart Infarction
6%
Infection
13%
Inflammation
27%
Inflammatory Disease
6%
Interferon
6%
Lead Compound
9%
Lung Cancer
9%
Malignant Neoplasm
47%
Metamizole
47%
Natural Product
9%
Phosphotransferase
23%
Phosphotransferase Inhibitor
9%
Proteasome Inhibitor
9%
Protein Kinase B
11%
Protein Kinase B Beta
47%
Pyrazole
11%
Pyrazole Derivative
47%
SARS Coronavirus
13%
Transcription Factors
6%
Transcriptome
6%
Trimethylglycine
9%